| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.0008 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |